Race Oncology Announces Director’s Final Notice

Race Oncology Ltd. (AU:RAC) has released an update.

Race Oncology Ltd has filed a final director’s interest notice indicating that Daniel Sharp ceased to be a director as of September 1, 2024. The notice details that Sharp held significant stock options, including 110,392 options at $3.32 expiring in 2028 and 139,516 options at $1.39 expiring in 2028. Additionally, Mary Harney is listed with 24,570 ordinary shares and 3,510 piggyback options exercisable at $1.25, set to expire in 2026.

For further insights into AU:RAC stock, check out TipRanks’ Stock Analysis page.